These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 34388587)

  • 1. High-dose intravenous vitamin C attenuates hyperinflammation in severe coronavirus disease 2019.
    Xia G; Fan D; He Y; Zhu Y; Zheng Q
    Nutrition; 2021; 91-92():111405. PubMed ID: 34388587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-dose vitamin C ameliorates cardiac injury in COVID-19 pandemic: a retrospective cohort study.
    Xia G; Qin B; Ma C; Zhu Y; Zheng Q
    Aging (Albany NY); 2021 Sep; 13(17):20906-20914. PubMed ID: 34499050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous high-dose vitamin C for the treatment of severe COVID-19: study protocol for a multicentre randomised controlled trial.
    Liu F; Zhu Y; Zhang J; Li Y; Peng Z
    BMJ Open; 2020 Jul; 10(7):e039519. PubMed ID: 32641343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anakinra combined with methylprednisolone in patients with severe COVID-19 pneumonia and hyperinflammation: An observational cohort study.
    Bozzi G; Mangioni D; Minoia F; Aliberti S; Grasselli G; Barbetta L; Castelli V; Palomba E; Alagna L; Lombardi A; Ungaro R; Agostoni C; Baldini M; Blasi F; Cesari M; Costantino G; Fracanzani AL; Montano N; Monzani V; Pesenti A; Peyvandi F; Sottocorno M; Muscatello A; Filocamo G; Gori A; Bandera A
    J Allergy Clin Immunol; 2021 Feb; 147(2):561-566.e4. PubMed ID: 33220354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CIGB-258, a peptide derived from human heat-shock protein 60, decreases hyperinflammation in COVID-19 patients.
    Hernandez-Cedeño M; Venegas-Rodriguez R; Peña-Ruiz R; Bequet-Romero M; Santana-Sanchez R; Penton-Arias E; Martinez-Donato G; Guillén-Nieto G; Dominguez-Horta MDC
    Cell Stress Chaperones; 2021 May; 26(3):515-525. PubMed ID: 33629254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laboratory Predictors of COVID-19 Mortality: A Retrospective Analysis from Tongji Hospital in Wuhan.
    Zheng T; Liu X; Wei Y; Li X; Zheng B; Gong Q; Dong L; Zhong J
    Mediators Inflamm; 2021; 2021():6687412. PubMed ID: 33679237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential benefit of high-dose intravenous vitamin C for coronavirus disease 2019 pneumonia.
    Zhao B; Li M; Ling Y; Peng Y; Huang J; Qu H; Gao Y; Li Y; Hu B; Lu S; Lu H; Zhang W; Mao E
    Chin Med J (Engl); 2022 Jan; 135(1):23-25. PubMed ID: 34873081
    [No Abstract]   [Full Text] [Related]  

  • 10. Low Vitamin D Status at Admission as a Risk Factor for Poor Survival in Hospitalized Patients With COVID-19: An Italian Retrospective Study.
    Infante M; Buoso A; Pieri M; Lupisella S; Nuccetelli M; Bernardini S; Fabbri A; Iannetta M; Andreoni M; Colizzi V; Morello M
    J Am Nutr Assoc; 2022; 41(3):250-265. PubMed ID: 33600292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose subcutaneous tocilizumab to prevent disease progression in patients with moderate COVID-19 pneumonia and hyperinflammation.
    Potere N; Di Nisio M; Rizzo G; La Vella M; Polilli E; Agostinone A; Spacone A; Di Carlo S; Costantini A; Abbate A; Porreca E; Parruti G
    Int J Infect Dis; 2020 Nov; 100():421-424. PubMed ID: 32768701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effectiveness of high-dose intravenous vitamin C for patients with coronavirus disease 2019: A systematic review and meta-analysis.
    Kwak SG; Choo YJ; Chang MC
    Complement Ther Med; 2022 Mar; 64():102797. PubMed ID: 34953366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitamin C as prophylaxis and adjunctive medical treatment for COVID-19?
    Feyaerts AF; Luyten W
    Nutrition; 2020; 79-80():110948. PubMed ID: 32911430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Characteristics and Outcome of Hospitalized COVID-19 Patients in a MERS-CoV Endemic Area.
    Barry M; AlMohaya A; AlHijji A; Akkielah L; AlRajhi A; Almajid F; Alsharidi A; Al-Shahrani FS; Alotaibi NH; Alanazi A; Ghonem L; Alhetheel A; Alsubaie S; Memish ZA
    J Epidemiol Glob Health; 2020 Sep; 10(3):214-221. PubMed ID: 32954712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin A Plasma Levels in COVID-19 Patients: A Prospective Multicenter Study and Hypothesis.
    Tepasse PR; Vollenberg R; Fobker M; Kabar I; Schmidt H; Meier JA; Nowacki T; Hüsing-Kabar A
    Nutrients; 2021 Jun; 13(7):. PubMed ID: 34202697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of high-dose intravenous vitamin C on prognosis in patients with SARS-CoV-2 pneumonia.
    Suna K; Melahat UŞ; Murat Y; Figen ÖE; Ayperi Ö
    Med Clin (Barc); 2022 Apr; 158(8):356-360. PubMed ID: 34103164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Essential metals, vitamins and antioxidant enzyme activities in COVID-19 patients and their potential associations with the disease severity.
    Al-Saleh I; Alrushud N; Alnuwaysir H; Elkhatib R; Shoukri M; Aldayel F; Bakheet R; Almozaini M
    Biometals; 2022 Feb; 35(1):125-145. PubMed ID: 34993712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Routine laboratory testing to determine if a patient has COVID-19.
    Stegeman I; Ochodo EA; Guleid F; Holtman GA; Yang B; Davenport C; Deeks JJ; Dinnes J; Dittrich S; Emperador D; Hooft L; Spijker R; Takwoingi Y; Van den Bruel A; Wang J; Langendam M; Verbakel JY; Leeflang MM;
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD013787. PubMed ID: 33211319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compassionate use of ruxolitinib in patients with SARS-Cov-2 infection not on mechanical ventilation: Short-term effects on inflammation and ventilation.
    Mortara A; Mazzetti S; Margonato D; Delfino P; Bersano C; Catagnano F; Lauriola M; Grosso P; Perseghin G; Ippoliti G
    Clin Transl Sci; 2021 May; 14(3):1062-1068. PubMed ID: 33403775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.